Seysara

Active Ingredient(s): Sarecycline Hydrochloride
FDA Approved: * October 1, 2018
Pharm Company: * ALLERGAN INC
Category: Antibiotics

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".

Seysara Overview

Sarecycline (trade name Seysara; development code WC-3035) is a tetracycline-derived antibiotic. In the United States, it was approved by the FDA in October 2018 for the treatment of moderate to severe acne vulgaris.[1] Paratek Pharmaceuticals, Inc. licensed the US rights to sarecycline for the treatment of acne in the United States to Actavis, a subsidiary of Allergan, while retaining rights in the rest of the world.[2] Allergan initiated a Phase 3 study in D...

Read more Seysara Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Sarecycline

Recent Seysara Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Sarecycline Hydrochloride

Tablet: 100mg, 150mg, 60mg

Note: Above list includes dosages for all drugs with the same combination of active ingredients.

NDC Database Records for Seysara: (3 results)

Sorted by National Drug Code

0023-6245 Seysara 60 mg Oral Tablet by Allergan, Inc.
0023-6246 Seysara 100 mg Oral Tablet by Allergan, Inc.
0023-6247 Seysara 150 mg Oral Tablet by Allergan, Inc.

Other drugs which contain Sarecycline Hydrochloride or a similar ingredient: (1 result)

SARECYCLINE